Factor XIII modulates intestinal epithelial wound healing in vitro

Area of Science:

• Gastroenterology
• Wound Healing Research
• Coagulation Factor Research

Background:

• Acquired deficiency of coagulation factor XIII (FXIII) is implicated in impaired intestinal wound healing and hemostasis in inflammatory bowel diseases.
• FXIII substitution therapy has shown promise in improving intestinal wound healing.
• The precise role of FXIII in modulating intestinal wound healing requires further in vitro characterization.

Purpose of the Study:

• To investigate the role of factor XIII in the modulation of intestinal wound healing in vitro.
• To characterize the effects of FXIII on intestinal epithelial cell proliferation and migration.

Main Methods:

• Cultured intestinal epithelial cell lines (IEC-6, IEC-18, T84, CaCo-2, HT-29) were treated with factor XIII.
• Cell proliferation was assessed using a MTT assay.
• Epithelial cell migration was evaluated using an in vitro wounding model.

Main Results:

• Factor XIII exhibited differential effects on cell proliferation, inhibiting IEC-6/18 cells but stimulating T84, CaCo-2, and HT-29 cells.
• Thrombin-activated factor XIII significantly enhanced intestinal epithelial cell restitution in vitro by approximately 2.5-fold.
• The effects of factor XIII were not significantly blocked by anti-transforming growth factor beta (TGF-beta).

Conclusions:

• Factor XIII may promote intestinal epithelial wound healing by enhancing cell restitution via a TGF-beta-independent pathway.
• These findings provide a potential mechanism for the observed beneficial effects of FXIII in treating active ulcerative colitis.
• Further research into FXIII's role in gastrointestinal healing is warranted.